CYDY
Price
$0.31
Change
-$0.01 (-3.12%)
Updated
Sep 3 closing price
Capitalization
390.48M
55 days until earnings call
GNNSF
Price
$2.20
Change
+$0.01 (+0.46%)
Updated
Aug 18 closing price
Capitalization
4.85B
Interact to see
Advertisement

CYDY vs GNNSF

Header iconCYDY vs GNNSF Comparison
Open Charts CYDY vs GNNSFBanner chart's image
CytoDyn
Price$0.31
Change-$0.01 (-3.12%)
Volume$825.49K
Capitalization390.48M
Genscript Biotech
Price$2.20
Change+$0.01 (+0.46%)
Volume$400
Capitalization4.85B
CYDY vs GNNSF Comparison Chart in %
Loading...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYDY vs. GNNSF commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYDY is a Hold and GNNSF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CYDY: $0.31 vs. GNNSF: $2.20)
Brand notoriety: CYDY and GNNSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYDY: 53% vs. GNNSF: 43%
Market capitalization -- CYDY: $390.48M vs. GNNSF: $4.85B
CYDY [@Biotechnology] is valued at $390.48M. GNNSF’s [@Biotechnology] market capitalization is $4.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYDY’s FA Score shows that 1 FA rating(s) are green whileGNNSF’s FA Score has 0 green FA rating(s).

  • CYDY’s FA Score: 1 green, 4 red.
  • GNNSF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CYDY and GNNSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYDY’s TA Score shows that 6 TA indicator(s) are bullish while GNNSF’s TA Score has 2 bullish TA indicator(s).

  • CYDY’s TA Score: 6 bullish, 4 bearish.
  • GNNSF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, CYDY is a better buy in the short-term than GNNSF.

Price Growth

CYDY (@Biotechnology) experienced а -1.27% price change this week, while GNNSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

CYDY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF($4.85B) has a higher market cap than CYDY($390M). CYDY YTD gains are higher at: 184.412 vs. GNNSF (73.228).
CYDYGNNSFCYDY / GNNSF
Capitalization390M4.85B8%
EBITDA8.59MN/A-
Gain YTD184.41273.228252%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash11.9MN/A-
Total Debt27.3MN/A-
FUNDAMENTALS RATINGS
CYDY vs GNNSF: Fundamental Ratings
CYDY
GNNSF
OUTLOOK RATING
1..100
1945
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
4240
P/E GROWTH RATING
1..100
10040
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYDY's Valuation (4) in the null industry is significantly better than the same rating for GNNSF (93). This means that CYDY’s stock grew significantly faster than GNNSF’s over the last 12 months.

GNNSF's Profit vs Risk Rating (96) in the null industry is in the same range as CYDY (100). This means that GNNSF’s stock grew similarly to CYDY’s over the last 12 months.

GNNSF's SMR Rating (97) in the null industry is in the same range as CYDY (100). This means that GNNSF’s stock grew similarly to CYDY’s over the last 12 months.

GNNSF's Price Growth Rating (40) in the null industry is in the same range as CYDY (42). This means that GNNSF’s stock grew similarly to CYDY’s over the last 12 months.

GNNSF's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for CYDY (100). This means that GNNSF’s stock grew somewhat faster than CYDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYDYGNNSF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNNSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSSB27.210.34
+1.27%
Return Stacked Global Stocks & Bonds ETF
QAT19.860.13
+0.66%
iShares MSCI Qatar ETF
CLIX55.830.35
+0.64%
ProShares Long Online/Short Stores ETF
CPSF24.930.02
+0.08%
Calamos S&P 500 Str Alt Prt ETF-Feb
EUSA101.69-0.26
-0.26%
iShares MSCI USA Equal Weighted ETF

CYDY and

Correlation & Price change

A.I.dvisor tells us that CYDY and TNXP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDY and TNXP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDY
1D Price
Change %
CYDY100%
-2.50%
TNXP - CYDY
22%
Poorly correlated
+0.14%
AGNPF - CYDY
21%
Poorly correlated
-19.35%
CLNN - CYDY
20%
Poorly correlated
-12.52%
GNNSF - CYDY
16%
Poorly correlated
N/A
GNMSF - CYDY
14%
Poorly correlated
+4.11%
More

GNNSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNNSF has been loosely correlated with SILO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GNNSF jumps, then SILO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
SILO - GNNSF
42%
Loosely correlated
-2.41%
SCNI - GNNSF
26%
Poorly correlated
+4.55%
CORT - GNNSF
25%
Poorly correlated
-0.06%
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
More